| Dr Diana Elizabeth Wilson, MD | |
|
1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104-2145 | |
| (817) 820-4280 | |
| (817) 820-4281 |
| Full Name | Dr Diana Elizabeth Wilson |
|---|---|
| Gender | Female |
| Speciality | Neurosurgery |
| Experience | 39 Years |
| Location | 1325 Pennsylvania Ave Ste 890, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538152400 | NPI | - | NPPES |
| 162405801 | Medicaid | TX | |
| 129595807 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | J0729 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Fort Worth | Fort worth, TX | Hospital |
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurosurgical And Spine Consultants, Pa | 1254231301 | 2 |
News Archive
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
Penwest Pharmaceuticals Co. today announced its financial results for the first quarter ended March 31, 2010. Compared with the first quarter of 2009, first quarter 2010 revenues increased sharply to $8.8 million, and operating expenses decreased by 20%. The Company had net income of $0.12 per share for the first quarter of 2010.
The labels on most prescription drug containers highlight the pharmacy's name or logo rather than instructions on how to take the medication, reports a new study in the September 10 issue of the Archives of Internal Medicine.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
Hitachi showcases Oasis Bore-Less MR at RSNA 2010, celebrating installations at premier healthcare providers and brand new clinical capabilities.
› Verified 5 days ago
| Entity Name | Neurosurgical And Spine Consultants, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164547733 PECOS PAC ID: 1254231301 Enrollment ID: O20040113000584 |
News Archive
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
Penwest Pharmaceuticals Co. today announced its financial results for the first quarter ended March 31, 2010. Compared with the first quarter of 2009, first quarter 2010 revenues increased sharply to $8.8 million, and operating expenses decreased by 20%. The Company had net income of $0.12 per share for the first quarter of 2010.
The labels on most prescription drug containers highlight the pharmacy's name or logo rather than instructions on how to take the medication, reports a new study in the September 10 issue of the Archives of Internal Medicine.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
Hitachi showcases Oasis Bore-Less MR at RSNA 2010, celebrating installations at premier healthcare providers and brand new clinical capabilities.
› Verified 5 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
Penwest Pharmaceuticals Co. today announced its financial results for the first quarter ended March 31, 2010. Compared with the first quarter of 2009, first quarter 2010 revenues increased sharply to $8.8 million, and operating expenses decreased by 20%. The Company had net income of $0.12 per share for the first quarter of 2010.
The labels on most prescription drug containers highlight the pharmacy's name or logo rather than instructions on how to take the medication, reports a new study in the September 10 issue of the Archives of Internal Medicine.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
Hitachi showcases Oasis Bore-Less MR at RSNA 2010, celebrating installations at premier healthcare providers and brand new clinical capabilities.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diana Elizabeth Wilson, MD 1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104-2145 Ph: (817) 820-4280 | Dr Diana Elizabeth Wilson, MD 1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104-2145 Ph: (817) 820-4280 |
News Archive
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
Penwest Pharmaceuticals Co. today announced its financial results for the first quarter ended March 31, 2010. Compared with the first quarter of 2009, first quarter 2010 revenues increased sharply to $8.8 million, and operating expenses decreased by 20%. The Company had net income of $0.12 per share for the first quarter of 2010.
The labels on most prescription drug containers highlight the pharmacy's name or logo rather than instructions on how to take the medication, reports a new study in the September 10 issue of the Archives of Internal Medicine.
DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
Hitachi showcases Oasis Bore-Less MR at RSNA 2010, celebrating installations at premier healthcare providers and brand new clinical capabilities.
› Verified 5 days ago
Anita Praful Bhansali, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 | |
Abdolreza Siadati, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Gregory Alan Ward, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 9th Ave, Suite 201, Fort Worth, TX 76104 Phone: 817-870-5094 Fax: 817-885-7352 | |
Philip C Bechtel, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1900 Mistletoe Blvd, Suite 200, Fort Worth, TX 76104 Phone: 817-878-5333 Fax: 817-878-5334 | |
Yves J. Meyer, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1325 Pennsylvania Ave Ste 890, Fort Worth, TX 76104 Phone: 817-820-4280 Fax: 817-820-4281 | |
Dr. Atif Haque, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 8th Ave Ste A1131, Fort Worth, TX 76104 Phone: 817-912-9250 | |
Adrian Timothy Harvey, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave Ste 500, Fort Worth, TX 76104 Phone: 817-250-4280 Fax: 817-250-4281 |